内页(新闻中心banner)
> News > NewsNews
Lu zhiyuan, Vice governor of Shaanxi province and the party visited Libang pharmaceutical
Source:本站原创    Posted by:力邦医疗产业集团    Views:56

On 3rd, July, 2018, accompanied by Zhang Xiaoning, director of SFDA, Lv Qiang, director of Xi’an FDA, Lu zhiyuan, Vice governor of Shaanxi province and the party visited Xi’an Libang pharmaceutical Co., Ltd to conduct deep survey. They got acquainted with production and management, technical research and development, intelligent manufacturing development. Li Tan, Chairman of Xi’an Libang Pharmaceutical Co., Ltd, Ju Jianbo, President of Xi’an Libang Healthcare Group Co., Ltd, Hui Minquan, General Manager of Xi’an Libang Pharmaceutical Co., Ltd, Hu huali, director of the libang pharmaceutical plant kept company with them.

 At the meeting, Ju jianbo extended a warm welcome to the leaders. At the same time, Ju expressed sincere support, care and help for governments at all levels. After that, he delivered a brief introduction from the aspects of production management, innovative development, talent cultivation and strategic planning.

During this period, Lu zhiyuan and the party had a cordial talk with everybody and asked detailed information about the production and quality management. Hu huali presented the plant layout, quality management, production process and focused on the production automation input of Li Mengxin Injection (Propofol Emulsion Injection) and Libang Xitong Injection (Alprostadil Injection) and the achievement of improvement of production efficiency.

In the end, Lu zhiyuan fully recognized the achievements in every aspects of Libang and it should be given support to as the key enterprise. He expressed that the enterprise which would develop first type new drug would be awarded 20,000,000RMB and the enterprise of which generic drug would pass the consistency evaluation would be awarded 3,000,000 RMB. At the same time, he claimed that the relative departments of the provincial government would create better and stable policy environment in order to support enterprises to become stronger and bigger. He hoped that Libang would continue creating the core competitiveness and become a huge enterprise with sales over 10 billion.

Libang will consider this survey as an opportunity and lay emphasis on improving product quality and GMP management level, tightening quality control to create more delicate products. Besides, Libang will devote itself to improving products technological level and innovation ability to realize its glorious goal-to make fresh contributions to the health of people.